Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 13,723 | 10,986 | 10,431 | 9,544 | 10,229 |
| Cost of Goods | 6,983 | 5,792 | 5,210 | 4,123 | 3,978 |
| Gross Profit | 6,740 | 5,194 | 5,221 | 5,421 | 6,251 |
| Operating Expenses | 8,677 | 7,433 | 5,674 | 4,654 | 5,106 |
| Operating Income | -954 | -1,447 | -243 | 890 | 2,122 |
| Other Income | -314 | -414 | -196 | -132 | -59 |
| Pre-tax Income | -1,267 | -1,860 | -439 | 758 | 2,064 |
| Income Tax | 28 | 462 | -270 | 250 | 850 |
| Net Income Continuous | -1,296 | -2,322 | -168 | 508 | 1,213 |
| Net Income | $-1,296 | $-2,322 | $-168 | $508 | $1,213 |
| EPS Basic Total Ops | -0.19 | -0.42 | -0.03 | 0.12 | 0.40 |
| EPS Basic Continuous Ops | -0.19 | -0.42 | -0.03 | 0.12 | 0.40 |
| EPS Diluted Total Ops | -0.19 | -0.42 | -0.03 | 0.12 | 0.38 |
| EPS Diluted Continuous Ops | -0.19 | -0.42 | -0.03 | 0.12 | 0.38 |
| EPS Diluted Before Non-Recurring Items | -0.19 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,331 | $91 | $662 | $1,693 | $2,648 |